TONI RAYBON: Open Payments
NPI 1013241843 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,284 in 113 payments from 22 companies in 2025. Trend: 2023 $2,664 · 2024 $2,337 · 2025 $2,284
Food & beverage: $2,284
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 11 | $299 |
| AstraZeneca Pharmaceuticals LP | 3 | $261 |
| ABBVIE INC. | 13 | $207 |
| Amgen Inc. | 14 | $177 |
| PFIZER INC. | 13 | $166 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $148 |
| Axsome Therapeutics, Inc. | 2 | $142 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $110 |
| Novo Nordisk Inc | 5 | $109 |
| Otsuka America Pharmaceutical, Inc. | 4 | $93 |
Products named: HETLIOZ, BREZTRI, JARDIANCE, OTEZLA, Auvelity, VRAYLAR, REXULTI, Kerendia.
Industry payments across KY — which companies pay providers there.
